- Home
- TELA vs SRTS Comparison
TELA vs SRTS Comparison
Compare TELA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- SRTS
- Stock Information
- Founded
- TELA 2012
- SRTS 2010
- Country
- TELA United States
- SRTS United States
- Employees
- TELA N/A
- SRTS N/A
- Industry
- TELA Medical/Dental Instruments
- SRTS Medical/Dental Instruments
- Sector
- TELA Health Care
- SRTS Health Care
- Exchange
- TELA Nasdaq
- SRTS Nasdaq
- Market Cap
- TELA 73.2M
- SRTS 75.5M
- IPO Year
- TELA 2019
- SRTS 2016
- Fundamental
- Price
- TELA $1.58
- SRTS $3.35
- Analyst Decision
- TELA Strong Buy
- SRTS Strong Buy
- Analyst Count
- TELA 4
- SRTS 3
- Target Price
- TELA $6.00
- SRTS $8.00
- AVG Volume (30 Days)
- TELA 82.9K
- SRTS 244.9K
- Earning Date
- TELA 08-11-2025
- SRTS 08-07-2025
- Dividend Yield
- TELA N/A
- SRTS N/A
- EPS Growth
- TELA N/A
- SRTS N/A
- EPS
- TELA N/A
- SRTS N/A
- Revenue
- TELA $75,323,000.00
- SRTS $37,564,000.00
- Revenue This Year
- TELA $26.67
- SRTS $4.33
- Revenue Next Year
- TELA $22.63
- SRTS $26.74
- P/E Ratio
- TELA N/A
- SRTS N/A
- Revenue Growth
- TELA 16.34
- SRTS 3.29
- 52 Week Low
- TELA $0.86
- SRTS $3.03
- 52 Week High
- TELA $3.26
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- TELA 41.66
- SRTS 31.02
- Support Level
- TELA $1.40
- SRTS $3.03
- Resistance Level
- TELA $2.14
- SRTS $3.45
- Average True Range (ATR)
- TELA 0.23
- SRTS 0.32
- MACD
- TELA -0.04
- SRTS -0.23
- Stochastic Oscillator
- TELA 24.32
- SRTS 11.07
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.